GSA Capital Partners’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03M	Buy	+133,710	New	+$976K	0.06%	481
2025 Q4	–	Sell	-49,012	Closed	-$903K	–	1660
2025 Q3	$903K	Buy	49,012 +9,459	+24%	+$152K	0.08%	459
2025 Q2	$515K	Buy	+39,553	New	+$468K	0.04%	903
2025 Q1	–	Sell	-29,476	Closed	-$500K	–	1632
2024 Q4	$500K	Buy	29,476 +20,059	+213%	+$378K	0.04%	886
2024 Q3	$219K	Sell	9,417 -52,213	-85%	-$1.12M	0.02%	1381
2024 Q2	$1.5M	Buy	+61,630	New	+$1.87M	0.1%	275
2023 Q2	–	Sell	-28,827	Closed	-$691K	–	1498
2023 Q1	$691K	Buy	28,827 +18,546	+180%	+$333K	0.07%	513
2022 Q4	$174K	Buy	+10,281	New	+$179K	0.02%	1214
2022 Q3	–	Sell	-51,848	Closed	-$816K	–	1494
2022 Q2	$816K	Buy	+51,848	New	+$1.02M	0.12%	220
2021 Q2	–	Sell	-5,311	Closed	-$219K	–	1304
2021 Q1	$219K	Sell	5,311 -1,200	-18%	-$71.5K	0.04%	844
2020 Q4	$282K	Buy	+6,511	New	+$441K	0.05%	774